Oasis Petroleum Inc. CHRD
We take great care to ensure that the data presented and summarized in this overview for Oasis Petroleum Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CHRD
View all-
Black Rock Inc. New York, NY5.1MShares$862 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.34MShares$732 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.23MShares$376 Million0.07% of portfolio
-
State Street Corp Boston, MA2.02MShares$342 Million0.02% of portfolio
-
Boston Partners Boston, MA1.31MShares$221 Million0.29% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA1.04MShares$176 Million0.82% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.03MShares$174 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA1.03MShares$173 Million0.02% of portfolio
-
American Century Companies Inc Kansas City, MO858KShares$145 Million0.1% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il735KShares$124 Million0.03% of portfolio
Latest Institutional Activity in CHRD
Top Purchases
Top Sells
About CHRD
Chord Energy Corporation operates as an independent exploration and production company. It acquires, exploits, develops, and explores for crude oil, natural gas, and natural gas liquids in the Williston Basin. The company was founded in 2007 and is headquartered in Houston, Texas.
Insider Transactions at CHRD
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 31
2024
|
Ward Polzin Director |
BUY
Grant, award, or other acquisition
|
Direct |
202
+50.0%
|
-
|
May 31
2024
|
Jeffrey Wayne Sheets Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,463
+50.0%
|
-
|
May 31
2024
|
Hilary A Foulkes Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,519
+50.0%
|
-
|
May 31
2024
|
Ian C Dundas Director |
BUY
Grant, award, or other acquisition
|
Direct |
75,481
+31.25%
|
-
|
May 01
2024
|
Marguerite Woung Chapman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+12.82%
|
-
|
May 01
2024
|
Kevin S Mc Carthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+5.34%
|
-
|
May 01
2024
|
Anne Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+8.47%
|
-
|
May 01
2024
|
Cynthia Lynn Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+5.03%
|
-
|
May 01
2024
|
Susan M Cunningham Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,426
+10.9%
|
-
|
May 01
2024
|
Samantha Holroyd Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+6.97%
|
-
|
May 01
2024
|
Paul Korus Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+7.63%
|
-
|
May 01
2024
|
Douglas E Brooks Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,042
+3.98%
|
-
|
Apr 15
2024
|
Daniel E Brown President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
55,287
-17.55%
|
$10,228,095
$185.31 P/Share
|
Apr 13
2024
|
Daniel E Brown President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,414
-1.69%
|
$1,012,418
$187.12 P/Share
|
Mar 04
2024
|
Richard N Robuck EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,268
+10.6%
|
-
|
Feb 20
2024
|
Michael H Lou EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
5,174
+3.73%
|
-
|
Feb 20
2024
|
Darrin J. Henke EVP and COO |
BUY
Grant, award, or other acquisition
|
Direct |
4,889
+42.84%
|
-
|
Feb 20
2024
|
Shannon Browning Kinney EVP, GC and Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
3,880
+14.04%
|
-
|
Feb 20
2024
|
Daniel E Brown President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,309
+3.12%
|
-
|
Feb 16
2024
|
Michael H Lou EVP and CFO |
SELL
Open market or private sale
|
Direct |
3,000
-2.29%
|
$495,000
$165.0 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 139K shares |
---|
Open market or private sale | 53.9K shares |
---|---|
Payment of exercise price or tax liability | 122K shares |